Nanoparticle technology shows promise for targeted diagnosis and treatment of atherosclerosis – Phys.org

Click here to sign in with or
Forget Password?
Learn more
share this!
18
9
Share
Email
June 23, 2022
by Baker Heart and Diabetes Institute
Baker Heart and Diabetes Institute researchers have designed and developed a novel drug delivery method that can vastly improve the efficacy of a drug used to treat atherosclerosis and has the potential to identify and treat other diseases.
The technique, using drug-loaded nanoparticles, directly targets the site of atherosclerosis in animal models, enhancing the cells’ uptake of the drug hydroxylpropyl-beta-cyclodextrin (CD) and significantly reducing cholesterol content more effectively than the drug alone.
Currently, high doses of CD are required during treatment of atherosclerosis, resulting in side effects including hearing loss, but sustained and local release of this drug-loaded nanoparticle (CDNP), would not only improve the efficacy of the drug but would also likely reduce those negative effects.
The study, led by Baker Institute Deputy Director, Basic and Translational Science Professor Karlheinz Peter, was published in the journal Small this week.
“We know that CD reduces cholesterol content in plaque but it is difficult to get the drugs to the area required, so you need a large amount,” study co-researcher and Baker Institute Laboratory Head, Molecular Imaging and Theranostics Associate Professor Xiaowei Wang said.
“We have packaged the drug into the nanoparticle, which is able to be sent directly to the site of disease. Once there, the drug accumulates and removes the cholesterol.
“We already know that CD is an effective treatment for other diseases, including Alzheimer’s disease and Niemann-Pick disease type C, so this technique has the potential to improve the treatment efficacy for those diseases, too.”
The nanoparticles have the added benefit of a gas core and fluorescent dye coating, which allows them to be used as a contrast agent for diagnostic imaging, Wang said.
“We can also visualize the nanoparticles on ultrasound, which would be a valuable diagnostic tool, and can pop the drug-filled bubble for immediate drug release using an ultrasound wave,” she said.
“We believe these CDNPs provide a platform for diagnostic and therapeutic delivery of anti-atherosclerotic therapy, and that CD-carrier platforms like CDNPs can be used for the co-delivery of multiple potent drugs.”
More information: Sourabh Mehta et al, An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis, Small (2022). DOI: 10.1002/smll.202200967
Journal information: Small
Provided by Baker Heart and Diabetes Institute
Explore further
Facebook
Twitter
Email
Feedback to editors
5 hours ago
0
6 hours ago
0
6 hours ago
0
8 hours ago
0
9 hours ago
1
13 minutes ago
17 minutes ago
1 hour ago
1 hour ago
1 hour ago
1 hour ago
1 hour ago
1 hour ago
2 hours ago
2 hours ago
7 hours ago
14 hours ago
15 hours ago
Sep 9, 2024
Sep 8, 2024
Sep 6, 2024
More from Biology and Medical
Jun 17, 2020
May 24, 2022
Dec 3, 2019
Nov 5, 2021
Nov 6, 2015
Oct 21, 2020
4 hours ago
Sep 16, 2024
Sep 16, 2024
Sep 16, 2024
Sep 13, 2024
Sep 13, 2024
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X’s mission by getting a premium account.
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web

source
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!